A Sub Study to Evaluate the Study Medication (Etrasimod) Using Wearable Sensors in Healthy Participants
Condition(s):Healthy ParticipantsLast Updated:February 20, 2024Active, not recruiting
Hide Studies Not Open or Pending
Condition(s):Healthy ParticipantsLast Updated:February 20, 2024Active, not recruiting
Condition(s):Attention-Deficit Hyperactivity DisorderLast Updated:December 23, 2021Completed
Condition(s):Sensitisation; Highly Sensitised Dialysis PatientsLast Updated:June 2, 2023Recruiting
Condition(s):MalariaLast Updated:September 29, 2022Completed
Condition(s):Rheumatoid ArthritisLast Updated:February 6, 2023Recruiting
Condition(s):Spinal Cord InjuriesLast Updated:January 25, 2021Terminated
Condition(s):Medication ManagementLast Updated:August 1, 2019Withdrawn
Condition(s):Visceral ProlapseLast Updated:December 23, 2022Active, not recruiting
Condition(s):Arthritis, RheumatoidLast Updated:March 28, 2024Not yet recruiting
Condition(s):Dyslipidemia; Diabetes; Prediabetes; Dysglycemia; Gout; Hypertension; Non-alcoholic Fatty Liver Disease; Cardiovascular DiseaseLast Updated:June 25, 2020Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.